New comment by Radiation Oncologist at University of Western Ontario Schulich School of Medicine & Dentistry ( January 24, 2024)
Oxybutynin also has evidence in the patient's refractory to other agents. It is appealing as it is non-hormonal. Our study found 70% sustained response rates. Over 85% did not...